PETER H O DONNELL

Allopathic & Osteopathic Physicians|Internal Medicine CHICAGO, IL NPI 1861695819

General Payments — all program years on this page

$322,066.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 187
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $109,727.34 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma Europe Ltd $41,977.005
Merck Sharp & Dohme Corporation $39,118.2518
PFIZER INC. $13,331.866
Astellas Pharma US Inc $4,522.633
ABBVIE INC. $2,865.602
EMD Serono, Inc. $2,662.001
IMMUNITYBIO, INC. $2,400.001
Eli Lilly and Company $1,600.001
Astellas Pharma Global Development $1,250.001

By program year

Program yearAmountRecords
2018 $21,934.5133
2019 $32,555.2743
2020 $29,572.4114
2021 $20,982.5015
2022 $22,277.3810
2023 $85,016.6234
2024 $109,727.3438

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105139356 ABBVIE INC. $115.60 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105139358 ABBVIE INC. $2,750.00 04/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1120280264 EMD Serono, Inc. $2,662.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1121140995 Astellas Pharma Europe Ltd $3,750.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1121140999 Astellas Pharma Europe Ltd $10,041.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1121141019 Astellas Pharma Europe Ltd $4,875.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1121141073 Astellas Pharma Europe Ltd $20,608.00 08/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1121141201 Astellas Pharma Europe Ltd $2,703.00 08/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125509266 IMMUNITYBIO, INC. $2,400.00 07/03/2024 Honoraria Undisputed 01/23/2026 View at CMS
1131475701 PFIZER INC. $245.73 03/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1131475705 PFIZER INC. $9,800.00 03/27/2024 Honoraria Undisputed 01/23/2026 View at CMS
1131475709 PFIZER INC. $550.00 02/07/2024 Honoraria Undisputed 01/23/2026 View at CMS
1131475713 PFIZER INC. $1,100.00 01/04/2024 Honoraria Undisputed 01/23/2026 View at CMS
1131475717 PFIZER INC. $73.63 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131484143 PFIZER INC. $1,562.50 01/16/2024 Honoraria Undisputed 01/23/2026 View at CMS
1132966825 Astellas Pharma Global Development $1,250.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135275439 Eli Lilly and Company $1,600.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139452158 Astellas Pharma US Inc $4,219.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139453586 Astellas Pharma US Inc $128.39 06/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139453588 Astellas Pharma US Inc $175.24 06/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141579977 Merck Sharp & Dohme LLC $610.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141660109 Merck Sharp & Dohme LLC $176.81 05/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141660111 Merck Sharp & Dohme LLC $48.22 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141660113 Merck Sharp & Dohme LLC $138.11 05/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141660115 Merck Sharp & Dohme LLC $21.43 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141660211 Merck Sharp & Dohme LLC $10,421.60 05/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141663911 Merck Sharp & Dohme LLC $138.11 05/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750425 Merck Sharp & Dohme LLC $48.09 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141750427 Merck Sharp & Dohme LLC $259.40 12/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750429 Merck Sharp & Dohme LLC $610.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141750431 Merck Sharp & Dohme LLC $150.00 12/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750433 Merck Sharp & Dohme LLC $8,345.20 12/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750435 Merck Sharp & Dohme LLC $150.00 05/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750445 Merck Sharp & Dohme LLC $1,220.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141750447 Merck Sharp & Dohme LLC $7,320.00 12/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1141750619 Merck Sharp & Dohme LLC $311.28 12/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141750621 Merck Sharp & Dohme LLC $8,540.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141853317 Merck Sharp & Dohme LLC $610.00 10/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.